Establishment Labs Holdings ROE 2017-2024 | ESTA

Current and historical return on equity (ROE) values for Establishment Labs Holdings (ESTA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Establishment Labs Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.07B $0.03B -185.62%
2024-06-30 $-0.08B $0.05B -221.33%
2024-03-31 $-0.08B $0.06B -207.50%
2023-12-31 $-0.08B $0.02B -363.22%
2023-09-30 $-0.07B $0.03B -472.13%
2023-06-30 $-0.06B $0.06B -751.52%
2023-03-31 $-0.08B $-0.02B 5466.67%
2022-12-31 $-0.08B $-0.01B -524.14%
2022-09-30 $-0.08B $0.00B -259.83%
2022-06-30 $-0.07B $0.02B -162.71%
2022-03-31 $-0.04B $0.05B -69.57%
2021-12-31 $-0.04B $0.05B -64.31%
2021-09-30 $-0.03B $0.06B -47.31%
2021-06-30 $-0.02B $0.07B -29.63%
2021-03-31 $-0.03B $0.07B -34.84%
2020-12-31 $-0.04B $0.08B -46.48%
2020-09-30 $-0.04B $0.08B -52.05%
2020-06-30 $-0.05B $0.08B -73.44%
2020-03-31 $-0.05B $0.09B -80.70%
2019-12-31 $-0.04B $0.04B -78.39%
2019-09-30 $-0.04B $0.04B -77.19%
2019-06-30 $-0.03B $0.05B -45.98%
2019-03-31 $-0.03B $0.06B -49.76%
2018-12-31 $-0.02B $0.07B -63.31%
2018-09-30 $-0.02B $0.08B -110.77%
2018-06-30 $-0.03B $0.00B 1000.00%
2018-03-31 $-0.04B $-0.01B 1057.14%
2017-12-31 $-0.04B $-0.01B 2800.00%
Sector Industry Market Cap Revenue
Medical Medical Services $1.206B $0.165B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Viatris (VTRS) United States $15.958B 4.92
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Medpace Holdings (MEDP) United States $10.498B 29.58
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00